Skip to main content
Biotest AG logo

Biotest AG — Investor Relations & Filings

Ticker · BIO3 ISIN · DE0005227201 LEI · 529900JVX7RPXBLYUD89 F Manufacturing
Filings indexed 1,148 across all filing types
Latest filing 2023-02-28 Report Publication Anno…
Country DE Germany
Listing F BIO3

Biotest AG is a global company that develops, manufactures, and supplies plasma protein products and biotherapeutic drugs. Sourced from human blood plasma, its products are primarily used in the therapeutic areas of clinical immunology, haematology, and intensive care medicine. The portfolio includes immunoglobulins (e.g., Intratect), coagulation factors, and albumins designed to treat severe and chronic diseases such as immune deficiencies, haemophilia, and coagulation disorders. The company manages the entire value chain from clinical development to sales and is advancing a pipeline of new treatments, including next-generation immunoglobulins (BT595) and fibrinogen concentrates (BT524). Biotest also provides Human Serum Albumin for use as a multifunctional excipient in pharmaceutical and diagnostic applications.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2023
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG". It explicitly states that it is announcing *when* and *where* future financial reports (specifically a 'Financial report of the group (half-year/Q2)' scheduled for August 10, 2023) will be disclosed, providing links to where they will be available. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports, rather than being the report itself (like an IR or 10-K). The document length is short (2130 chars), supporting the 'announcement' classification over the full report classification.
2023-02-28 English
Report Publication Announcement 2023
Report Publication Announcement Classification · 100% confidence The document is a 'Preliminary announcement of the publication of financial reports' for the business year 2022, specifically mentioning the upcoming disclosure of the 'Annual financial report of the group' on March 23, 2023. The text itself is not the full financial report (10-K or IR) but an announcement about when and where that report will be made available. According to Rule 2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of a report should be classified as a Report Publication Announcement (RPA). The document explicitly states the report type and the date of disclosure, fitting the RPA definition perfectly.
2023-02-28 English
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
Report Publication Announcement Classification · 100% confidence The document is a short notification (866 characters) announcing the availability of the 2022 Annual Report for Biotest AG. It provides a link to the report and specifies the publication date, rather than containing the full financial report itself. Per the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2023-02-28 German
Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis zum 30.06.2023
Report Publication Announcement Classification · 99% confidence The document is very short (893 characters) and explicitly functions as a notice. The subject line is "Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis 30.06.2023" (Notice of Half-Year Financial Report for the period 01.01.2023 to 30.06.2023). It provides a link where the report can be found and the date it was made available (10.08.2023). This structure perfectly matches the definition of a Report Publication Announcement (RPA), which announces the availability of a report rather than containing the report itself. The report being announced is a half-year report, which would typically be classified as 'IR' (Interim Report), but since this document is only the announcement, RPA is the correct classification based on Rule 2.
2023-02-28 German
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
Report Publication Announcement Classification · 98% confidence The document is very short (883 characters) and explicitly states that the 'Finanzbericht' (Financial Report) for the business year 2022 is available 'Im Internet unter:' (On the internet at:) and provides a link and a date (23.03.2023) when it became available. This structure—announcing the availability of a full report rather than containing the report itself—fits the definition of a Report Publication Announcement (RPA). The content refers to the annual financial report ('Konzernabschluss vom 01.01.2022 bis 31.12.2022'), but because this is just a notice of publication, RPA is the correct classification based on Rule 2 (The 'MENU VS MEAL' Rule).
2023-02-28 German
Biotest AG: Biotest Supervisory Board appoints new Management Board member
Board/Management Information Classification · 100% confidence The document is a press release announcing a change in senior management: the appointment of Ainhoa Mendizabal as the new Chief Financial Officer (CFO) of Biotest AG's Management Board. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in senior management.
2023-02-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.